Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 14;13(6):1102.
doi: 10.3390/diagnostics13061102.

Artificial Intelligence-Aided Endoscopy and Colorectal Cancer Screening

Affiliations
Review

Artificial Intelligence-Aided Endoscopy and Colorectal Cancer Screening

Marco Spadaccini et al. Diagnostics (Basel). .

Abstract

Colorectal cancer (CRC) is the third most common cancer worldwide, with the highest incidence reported in high-income countries. However, because of the slow progression of neoplastic precursors, along with the opportunity for their endoscopic detection and resection, a well-designed endoscopic screening program is expected to strongly decrease colorectal cancer incidence and mortality. In this regard, quality of colonoscopy has been clearly related with the risk of post-colonoscopy colorectal cancer. Recently, the development of artificial intelligence (AI) applications in the medical field has been growing in interest. Through machine learning processes, and, more recently, deep learning, if a very high numbers of learning samples are available, AI systems may automatically extract specific features from endoscopic images/videos without human intervention, helping the endoscopists in different aspects of their daily practice. The aim of this review is to summarize the current knowledge on AI-aided endoscopy, and to outline its potential role in colorectal cancer prevention.

Keywords: cancer; colonoscopy; innovation; screening; technology.

PubMed Disclaimer

Conflict of interest statement

M.S.: none. D.M.: none. Y.M.: consulting for Olympus Corp.; ownership interest in Cybernet Corp. L.A.: none. A.F.: none. R.M.: consulting fees for Fuji. P.S.: consulting fees for Fuji. C.H.: consulting fees for Fuji and Medtronic. A.R.: consulting fees for Fuji, Olympus, and Medtronic.

Figures

Figure 1
Figure 1
Neural networks and subsets of artificial intelligence.
Figure 2
Figure 2
Application of a Computer-Aided Detection (CADe) system (GI-Genius, Medtronic Corp, Minneapolis, MN, USA).
Figure 3
Figure 3
Application of a Computer-Aided Characterization (CADx) system (CAD-EYE, Fujifilm, Japan).
Figure 4
Figure 4
Example of false positive activation of two different Computer-Aided Detection systems due to colonic fold and stool residue.

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Siegel R.L., Miller K.D., Jemal A. Cancer Statistics, 2018. CA Cancer J. Clin. 2018;68:7–30. doi: 10.3322/caac.21442. - DOI - PubMed
    1. Arnold M., Sierra M.S., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Patterns and Trends in Colorectal Cancer Incidence and Mortality. Gut. 2017;66:683–691. doi: 10.1136/gutjnl-2015-310912. - DOI - PubMed
    1. Brenner H., Kloor M., Pox C.P. Colorectal Cancer. Lancet. 2014;383:1490–1502. doi: 10.1016/S0140-6736(13)61649-9. - DOI - PubMed
    1. Nishihara R., Wu K., Lochhead P., Morikawa T., Liao X., Qian Z.R., Inamura K., Kim S.A., Kuchiba A., Yamauchi M., et al. Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy. N. Engl. J. Med. 2013;369:1095–1105. doi: 10.1056/NEJMoa1301969. - DOI - PMC - PubMed

LinkOut - more resources